Compare Kenvue Inc. Common Stock (KVUE) vs Vivmark Residential Common Shares of Beneficial Interest (VMRK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kenvue Inc. Common Stock vs Vivmark Residential Common Shares of Beneficial Interest — how do they compare? Kenvue Inc. Common Stock trades at $17.7 (market cap $34.06B), while Vivmark Residential Common Shares of Beneficial Interest trades at $61.24 (market cap $46.41B). The key difference: Vivmark Residential Common Shares of Beneficial Interest is the larger of the two by market cap, and Kenvue Inc. Common Stock pays the higher dividend (4.74%). Which is the better fit depends on your goals.
| KVUE | VMRK | |
|---|---|---|
Market Cap | $34.06B | $46.41B |
Volume | 23,267,228 | 6,584,008 |
Sector | Consumer Staples | Real Estate |
52-Week High | $19.83 | $70.15 |
52-Week Low | $14.11 | $57.98 |
Enterprise Value | $41.56B | $55.52B |
Dividend Yield | 4.74% | 4.68% |
Typical Hold Time | — | 1 Days |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kenvue Inc. Common Stock
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →About Vivmark Residential Common Shares of Beneficial Interest
Vivmark Residential is a residential real estate investment trust that owns and operates apartment communities in U.S. markets. Its portfolio includes apartment homes and development projects.
Read more on VMRK →
